Narwhal Capital Management trimmed its holdings in Abbott Laboratories ( NYSE:ABT – Get Rating ) by 2.1% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 36,380 shares of the healthcare product maker's stock after selling 780 shares during the quarter. Narwhal Capital Management's holdings in Abbott Laboratories were worth $3,994,000 as of its most recent SEC filing. A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business.

https://www.dailypolitical.com/2023/04/11/abbott-laboratories-nyseabt-shares-sold-by-narwhal-capital-management.html

#dailypolitical